SCHEMBL14009168

SCHEMBL14009168

COc1ccc(NC(=O)c2ccc(C(=O)Nc3ccc(N4CCCCC4)cc3)s2)c(C)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 13/20 0.57
▸ ALDH1A1 P00352 8/20 0.57
▸ KMT2A Q03164 7/20 0.57
▸ RAB9A P51151 6/20 0.57
▸ MCL1 Q07820 3/20 0.57
▸ NR4A1 P22736 2/20 0.57
▸ SMN1; SMN2 Q16637 5/20 0.56
▸ NPC1 O15118 4/20 0.56
▸ LMNA P02545 2/20 0.56
▸ QSOX1 O00391 1/20 0.56
▸ PKM P14618 1/20 0.56
▸ F10 P00742 3/20 0.54
▸ GFER P55789 2/20 0.50
▸ MEN1 O00255 4/20 0.49
▸ KDM4E B2RXH2 3/20 0.49
▸ MAPK1 P28482 3/20 0.49
▸ USP2 O75604 2/20 0.49
▸ ALOX15 P16050 1/20 0.49
▸ AHR P35869 1/20 0.49
▸ L3MBTL1 Q9Y468 3/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14009155 0.91 L3MBTL1 (0.60) MAPTALDH1A1KMT2ARAB9AMCL1
SCHEMBL14009227 0.91 NPC1 (0.60) MAPTKMT2ARAB9ASMN1; SMN2NPC1
SCHEMBL14009225 0.90 MAPKAPK2 (0.53) MAPTALDH1A1KMT2ARAB9AMCL1
SCHEMBL14009158 0.81 NPC1 (0.54) MAPTALDH1A1KMT2ARAB9ASMN1; SMN2
SCHEMBL14009284 0.80 CA1 (0.50) MAPTALDH1A1KMT2ARAB9ASMN1; SMN2
SCHEMBL14009231 0.80 MAPT (0.52) MAPTALDH1A1KMT2ARAB9AMCL1
SCHEMBL14009187 0.79 MEN1 (0.48) MAPTALDH1A1KMT2ASMN1; SMN2LMNA
SCHEMBL14009015 0.79 MAPT (0.46) MAPTKMT2ARAB9ASMN1; SMN2NPC1
SCHEMBL14009173 0.79 KLKB1 (0.57) MAPTKMT2ASMN1; SMN2NPC1LMNA
SCHEMBL14009222 0.79 RXFP1 (0.51) MAPTKMT2ARAB9ASMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7446195-B2 High affinity thiophene-based and furan-based kinase ligands SCHERING CORPORATION (US) 2008-11-04 — — US disclosed
US-7446195-B2 High affinity thiophene-based and furan-based kinase ligands SCHERING CORPORATION (US) 2008-11-04 — — US disclosed
US-20070043045-A1 Novel high affinity thiophene-based and furan-based kinase ligands SCHERING CORPORATION 2007-02-22 — — US disclosed
US-20070043045-A1 Novel high affinity thiophene-based and furan-based kinase ligands SCHERING CORPORATION 2007-02-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070043045-A1 Novel high affinity thiophene-based and furan-based kinase ligands CDKL2, CDK2, CDKL1 MAPT 2145/4885ALDH1A1 4225/4885KMT2A 806/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback